Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Dong-A's analgesic drug candidate in clinical trials

Nov. 1, 1996

Glaxo Wellcome anesthetic receives European clearance

Oct. 25, 1996

Novel antimigraine agent launched in the U.K.

Oct. 25, 1996

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Neurex broadens clinical program for SNX-111

Oct. 25, 1996

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Oct. 25, 1996

Efficacy of Ampligen demonstrated in chronic fatigue syndrome

Oct. 25, 1996

Clinical trials with Bradycor suspended pending clarification of anomalous animal findings

Oct. 25, 1996

NS-1201 available for licensing

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...